Curious to see your top suppliers emissions?
Book a demo for a pilot project
Jeil Pharmaceutical Co.,Ltd
Pharmaceutical Preparation ManufacturingSouth Korea
Last verified 11 months agojeilpharm.co.kr
Jeil Pharmaceutical Co., Ltd., commonly referred to as Jeil Pharma, is a prominent player in the pharmaceutical industry, headquartered in South Korea (KR). Established in 1973, the company has made significant strides in developing innovative healthcare solutions, focusing on areas such as oncology, cardiology, and neurology.
With a strong presence in both domestic and international markets, Jeil Pharma is recognised for its commitment to research and development, leading to the creation of unique products that address unmet medical needs. The company’s core offerings include a range of prescription medications and advanced therapeutic solutions, which have garnered a reputation for quality and efficacy.
Jeil Pharmaceutical's dedication to excellence has positioned it as a trusted name in the industry, with notable achievements in expanding its global footprint and enhancing patient care through cutting-edge treatments.
20
DitchCarbon score
-22 vs industry average
Jeil Pharmaceutical Co.,Ltd’s score of 20 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Jeil Pharmaceutical Co.,Ltd?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Jeil Pharmaceutical Co.,Ltd yet.
Jeil Pharmaceutical Co.,Ltd's reported carbon emissions
Jeil Pharmaceutical Co., Ltd, headquartered in South Korea (KR), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Jeil Pharmaceutical may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, the company's climate commitments remain unclear, and it appears to be operating without a defined strategy for addressing carbon emissions or sustainability within the pharmaceutical sector.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Jeil Pharmaceutical Co.,Ltd’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Jeil Pharmaceutical Co.,Ltd yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Jeil Pharmaceutical Co.,Ltd11 months ago
20
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more